REQUEST A DEMO
Total
USD $0.00
Search more companies

Tanabe Pharma Singapore Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: All Other Business Support Services
Full name: Tanabe Pharma Singapore Pte. Ltd. Profile Updated: April 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Tanabe Pharma Singapore Pte. Ltd. is an enterprise located in Singapore, with the main office in Singapore. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on January 28, 2016. It currently has a total number of Below 50 (estimated) employees. The latest financial highlights indicate a net sales revenue increase of 1.46% in 2025. During that time, Tanabe Pharma Singapore Pte. Ltd.’s total assets grew by 3.28%. In, 2025, the company’s net profit margin decreased by 6.1%.

Legal Address
9 Raffles Place, #09-01, Republic Plaza, Singapore 048619
Singapore; Singapore; Postal Code: 048619

Contact Details: Purchase the Tanabe Pharma Singapore Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Tanabe Pharma Singapore Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Tanabe Pharma Singapore Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Tanabe Pharma Singapore Pte. Ltd. report to view the information.
Incorporation Date:
January 28, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director, Managing Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Tanabe Pharma Singapore Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
1.46%
Total Operating Revenue
1.46%
Net Profit/Loss for the Period
-42.4%
Total Assets
3.28%
Total Equity
11.71%
Net Profit Margin
-6.1%
Return on Equity (ROE)
-9.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?